ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire August 01, 2025 SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) — ImageneBio, Inc. (Nasdaq: IMA) (“ImageneBio”), a clinical stage biotechnology company dedicated to developing treatments for immunological/autoimmune and inflammatory (“I&I”) diseases, granted equity awards to Dr. Kristin Yarema, ImageneBio's recently appointed Chief Executive Officer, on […]